# Karyopharm Therapeutics Inc. > Alpha governed public record. Unknown, unavailable, and unpublished values are never inferred as zero. ## Record | Field | Value | | --- | --- | | Representation | alpha-profile-markdown-v4 | | Protocol | Alpha Governance Facts Protocol 0.1 | | Schema | alpha.governance.entity.public.v1 | | Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | | Governance record representation | alpha-governance-record-v2 | | Canonical entity | alpha:company:d9e3a59e-f440-41c2-966e-06e1ac24c545 | | Entity type | Company | | Canonical URL | https://registry.alpha.ac/companies/karyopharm-therapeutics-inc | | Publication | PUBLISHED | | Verification | source_reported | | Verification schema | alpha-verification-states-v1 | | Ownership | unclaimed | | Published claims | 25 | | Claims under review | 1 | | Evidence records | 9 | | Conflicts | 0 | | Conflicts in internal review | 0 | | Observed | 2026-10-16T13:53:41.002909+00:00 | | Last reviewed | 2026-10-16T13:53:41.002909+00:00 | ## Identity - Legal name: Karyopharm Therapeutics Inc. - Display name: Karyopharm Therapeutics Inc. ## Alpha Governance Record | Field | Value | | --- | --- | | Governance Record schema | alpha-governance-record-v2 | | Ontology | alpha-governance-ontology-v1 | | Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | | As of | 2026-10-16T17:33:15.770778+00:00 | | Completeness | 0.409 | | Record Quality | 0.846 | | Directors | 7 | | Committees | 5 | | Governance events | 17 | | Entity class | public_company | ## Section coverage | Section | State | | --- | --- | | identity | PUBLISHED | | corporate_structure | NOT_REVIEWED | | board | PUBLISHED | | committees | PUBLISHED | | leadership | PUBLISHED | | ownership | NOT_REVIEWED | | financials | NOT_REVIEWED | | capital_structure | PUBLISHED | | compensation | NOT_REVIEWED | | governance | NOT_REVIEWED | | shareholder_governance | NOT_REVIEWED | | audit | NOT_REVIEWED | | legal | NOT_REVIEWED | | risk | NOT_REVIEWED | | cyber | NOT_REVIEWED | | ai_governance | NOT_REVIEWED | | agent_governance | RESTRICTED | | markets_external | NOT_REVIEWED | | events | PUBLISHED | | relationships | PUBLISHED | | assessments | PUBLISHED | | evidence | PUBLISHED | ## Board - Barry E. Greene: Director. Status: current. Independent: true. Since: 2013-01-01. Committees: Compensation (member); Compensation; Nominating and Governance · Chair (member); Nominating and Governance (chair). claim_id=alpha:claim:company:d9e3a59e-f440-41c2-966e-06e1ac24c545:leadership_role:5 - Christy J. Oliger: Director. Status: current. Independent: true. Since: 2020-01-01. Committees: Compensation (member). claim_id=alpha:claim:company:d9e3a59e-f440-41c2-966e-06e1ac24c545:leadership_role:6 - Cynthia L. Anderson, CPA: Director. Status: current. Independent: true. Since: 2020-01-01. claim_id=alpha:claim:company:d9e3a59e-f440-41c2-966e-06e1ac24c545:leadership_role:7 - Deepika R. Pakianathan, Ph.D.: Director. Status: current. Independent: true. Since: 2013-01-01. claim_id=alpha:claim:company:d9e3a59e-f440-41c2-966e-06e1ac24c545:leadership_role:8 - Garen G. Bohlin: Director. Status: current. Independent: true. Since: 2013-01-01. Committees: Audit (chair); Audit · Chair; Nominating and Governance (member); Nominating and Governance (member). claim_id=alpha:claim:company:d9e3a59e-f440-41c2-966e-06e1ac24c545:leadership_role:9 - Richard Paulson, M.B.A.: Director. Status: current. Independent: false. Since: 2020-01-01. claim_id=alpha:claim:company:d9e3a59e-f440-41c2-966e-06e1ac24c545:leadership_role:10 - Zhen Su, M.D., M.B.A.: Director. Status: current. Independent: true. Since: 2023-01-01. claim_id=alpha:claim:company:d9e3a59e-f440-41c2-966e-06e1ac24c545:leadership_role:11 ## Committees - Audit (audit). Chair: Garen G. Bohlin. Members: Garen G. Bohlin (chair, current). committee_id=alpha:committee:karyopharm-therapeutics-inc:audit - Audit · Chair; Nominating and Governance (audit). Chair: NOT_PUBLISHED. Members: Garen G. Bohlin (member, current). committee_id=alpha:committee:karyopharm-therapeutics-inc:audit-chair-nominating-and-governance - Compensation (compensation). Chair: NOT_PUBLISHED. Members: Barry E. Greene (member, current); Christy J. Oliger (member, current). committee_id=alpha:committee:karyopharm-therapeutics-inc:compensation - Compensation; Nominating and Governance · Chair (compensation). Chair: NOT_PUBLISHED. Members: Barry E. Greene (member, current). committee_id=alpha:committee:karyopharm-therapeutics-inc:compensation-nominating-and-governance-chair - Nominating and Governance (nominating_governance). Chair: Barry E. Greene. Members: Barry E. Greene (chair, current); Garen G. Bohlin (member, current). committee_id=alpha:committee:karyopharm-therapeutics-inc:nominating-and-governance ## Executive leadership - Lori Macomber, C.P.A.: Executive Vice President, Chief Financial Officer and Treasurer [CFO]. Status: current. claim_id=alpha:claim:company:d9e3a59e-f440-41c2-966e-06e1ac24c545:leadership_role:12 - Michael V. Greco, J.D.: Executive Vice President, Chief Legal Officer and Secretary [GC]. Status: current. claim_id=alpha:claim:company:d9e3a59e-f440-41c2-966e-06e1ac24c545:leadership_role:13 - Reshma Rangwala, M.D., Ph.D.: Executive Vice President, Chief Medical Officer. Status: current. claim_id=alpha:claim:company:d9e3a59e-f440-41c2-966e-06e1ac24c545:leadership_role:14 - Richard Paulson, M.B.A.: President and Chief Executive Officer [CEO]. Status: current. claim_id=alpha:claim:company:d9e3a59e-f440-41c2-966e-06e1ac24c545:leadership_role:15 - Sohanya Cheng, M.B.A.: Executive Vice President, Chief Commercial Officer. Status: current. claim_id=alpha:claim:company:d9e3a59e-f440-41c2-966e-06e1ac24c545:leadership_role:16 - Stuart Poulton: Executive Vice President, Chief Development Officer. Status: current. claim_id=alpha:claim:company:d9e3a59e-f440-41c2-966e-06e1ac24c545:leadership_role:17 ## Governance events - CFO_CHANGED: Lori Macomber, C.P.A. executive of Karyopharm Therapeutics Inc., effective 2026-02-13. Effective: 2026-02-13. Detected: 2026-10-16T13:53:41.002909+00:00. event_id=alpha:event:transition:dg087jy0i5d5 - GC_CHANGED: Michael V. Greco, J.D. executive of Karyopharm Therapeutics Inc., effective 2026-02-13. Effective: 2026-02-13. Detected: 2026-10-16T13:53:41.002909+00:00. event_id=alpha:event:transition:1ly8mbdv96ctb - EXECUTIVE_APPOINTED: Reshma Rangwala, M.D., Ph.D. executive of Karyopharm Therapeutics Inc., effective 2026-02-13. Effective: 2026-02-13. Detected: 2026-10-16T13:53:41.002909+00:00. event_id=alpha:event:transition:17jw31z18716kn - CEO_CHANGED: Richard Paulson, M.B.A. executive of Karyopharm Therapeutics Inc., effective 2026-02-13. Effective: 2026-02-13. Detected: 2026-10-16T13:53:41.002909+00:00. event_id=alpha:event:transition:p9ze824jnlv4 - EXECUTIVE_APPOINTED: Sohanya Cheng, M.B.A. executive of Karyopharm Therapeutics Inc., effective 2026-02-13. Effective: 2026-02-13. Detected: 2026-10-16T13:53:41.002909+00:00. event_id=alpha:event:transition:fb5mle7dbyzu - EXECUTIVE_APPOINTED: Stuart Poulton executive of Karyopharm Therapeutics Inc., effective 2026-02-13. Effective: 2026-02-13. Detected: 2026-10-16T13:53:41.002909+00:00. event_id=alpha:event:transition:15k4p1f1jemc1f - DIRECTOR_APPOINTED: Zhen Su, M.D., M.B.A. seat on Karyopharm Therapeutics Inc., effective 2023-01-01. Effective: 2023-01-01. Detected: 2026-10-16T13:53:41.002909+00:00. event_id=alpha:event:transition:15oyqnq1qzzls - DIRECTOR_APPOINTED: Christy J. Oliger seat on Karyopharm Therapeutics Inc., effective 2020-01-01. Effective: 2020-01-01. Detected: 2026-10-16T13:53:41.002909+00:00. event_id=alpha:event:transition:1047dw92ag5wh - DIRECTOR_APPOINTED: Cynthia L. Anderson, CPA seat on Karyopharm Therapeutics Inc., effective 2020-01-01. Effective: 2020-01-01. Detected: 2026-10-16T13:53:41.002909+00:00. event_id=alpha:event:transition:xfx14u61fpjo - DIRECTOR_APPOINTED: Richard Paulson, M.B.A. seat on Karyopharm Therapeutics Inc., effective 2020-01-01. Effective: 2020-01-01. Detected: 2026-10-16T13:53:41.002909+00:00. event_id=alpha:event:transition:1o24k72148ob26 - DIRECTOR_APPOINTED: Barry E. Greene seat on Karyopharm Therapeutics Inc., effective 2013-01-01. Effective: 2013-01-01. Detected: 2026-10-16T13:53:41.002909+00:00. event_id=alpha:event:transition:m9mfh27tzypu - DIRECTOR_APPOINTED: Deepika R. Pakianathan, Ph.D. seat on Karyopharm Therapeutics Inc., effective 2013-01-01. Effective: 2013-01-01. Detected: 2026-10-16T13:53:41.002909+00:00. event_id=alpha:event:transition:16kpsm91gn3k37 - DIRECTOR_APPOINTED: Garen G. Bohlin seat on Karyopharm Therapeutics Inc., effective 2013-01-01. Effective: 2013-01-01. Detected: 2026-10-16T13:53:41.002909+00:00. event_id=alpha:event:transition:18m6pdizn9nn2 - COMMITTEE_CREATED: Audit · Chair; Nominating and Governance committee of Karyopharm Therapeutics Inc., effective 2013-01-01. Effective: 2013-01-01. Detected: 2026-10-16T13:53:41.002909+00:00. event_id=alpha:event:transition:354kvu1bfk9me - COMMITTEE_MEMBER_ADDED: Garen G. Bohlin member of Audit · Chair; Nominating and Governance, effective 2013-01-01. Effective: 2013-01-01. Detected: 2026-10-16T13:53:41.002909+00:00. event_id=alpha:event:transition:1xcbi9mftzz3q - COMMITTEE_CREATED: Compensation; Nominating and Governance · Chair committee of Karyopharm Therapeutics Inc., effective 2013-01-01. Effective: 2013-01-01. Detected: 2026-10-16T13:53:41.002909+00:00. event_id=alpha:event:transition:131p3ig1ehbzxy - COMMITTEE_MEMBER_ADDED: Barry E. Greene member of Compensation; Nominating and Governance · Chair, effective 2013-01-01. Effective: 2013-01-01. Detected: 2026-10-16T13:53:41.002909+00:00. event_id=alpha:event:transition:punw15n2vtwn ## Scoped resources - `alpha://company/karyopharm-therapeutics-inc` (contract): https://registry.alpha.ac/api/public/companies/karyopharm-therapeutics-inc?format=record - `alpha://company/karyopharm-therapeutics-inc/identity` (contract): https://registry.alpha.ac/api/public/companies/karyopharm-therapeutics-inc?format=record§ion=identity - `alpha://company/karyopharm-therapeutics-inc/corporate-structure` (contract): https://registry.alpha.ac/api/public/companies/karyopharm-therapeutics-inc?format=record§ion=corporate-structure - `alpha://company/karyopharm-therapeutics-inc/board` (contract): https://registry.alpha.ac/api/public/companies/karyopharm-therapeutics-inc?format=record§ion=board - `alpha://company/karyopharm-therapeutics-inc/committees` (contract): https://registry.alpha.ac/api/public/companies/karyopharm-therapeutics-inc?format=record§ion=committees - `alpha://company/karyopharm-therapeutics-inc/leadership` (contract): https://registry.alpha.ac/api/public/companies/karyopharm-therapeutics-inc?format=record§ion=leadership - `alpha://company/karyopharm-therapeutics-inc/ownership` (contract): https://registry.alpha.ac/api/public/companies/karyopharm-therapeutics-inc?format=record§ion=ownership - `alpha://company/karyopharm-therapeutics-inc/financials` (contract): https://registry.alpha.ac/api/public/companies/karyopharm-therapeutics-inc?format=record§ion=financials - `alpha://company/karyopharm-therapeutics-inc/capital-structure` (contract): https://registry.alpha.ac/api/public/companies/karyopharm-therapeutics-inc?format=record§ion=capital-structure - `alpha://company/karyopharm-therapeutics-inc/compensation` (contract): https://registry.alpha.ac/api/public/companies/karyopharm-therapeutics-inc?format=record§ion=compensation - `alpha://company/karyopharm-therapeutics-inc/governance` (contract): https://registry.alpha.ac/api/public/companies/karyopharm-therapeutics-inc?format=record§ion=governance - `alpha://company/karyopharm-therapeutics-inc/shareholder-governance` (contract): https://registry.alpha.ac/api/public/companies/karyopharm-therapeutics-inc?format=record§ion=shareholder-governance - `alpha://company/karyopharm-therapeutics-inc/audit` (contract): https://registry.alpha.ac/api/public/companies/karyopharm-therapeutics-inc?format=record§ion=audit - `alpha://company/karyopharm-therapeutics-inc/legal` (contract): https://registry.alpha.ac/api/public/companies/karyopharm-therapeutics-inc?format=record§ion=legal - `alpha://company/karyopharm-therapeutics-inc/risk` (contract): https://registry.alpha.ac/api/public/companies/karyopharm-therapeutics-inc?format=record§ion=risk - `alpha://company/karyopharm-therapeutics-inc/cyber` (contract): https://registry.alpha.ac/api/public/companies/karyopharm-therapeutics-inc?format=record§ion=cyber - `alpha://company/karyopharm-therapeutics-inc/ai-governance` (contract): https://registry.alpha.ac/api/public/companies/karyopharm-therapeutics-inc?format=record§ion=ai-governance - `alpha://company/karyopharm-therapeutics-inc/agents` (contract): https://registry.alpha.ac/api/public/companies/karyopharm-therapeutics-inc?format=record§ion=agents - `alpha://company/karyopharm-therapeutics-inc/ecosystem` (contract): https://registry.alpha.ac/api/public/companies/karyopharm-therapeutics-inc?format=record§ion=ecosystem - `alpha://company/karyopharm-therapeutics-inc/events` (contract): https://registry.alpha.ac/api/public/companies/karyopharm-therapeutics-inc?format=record§ion=events - `alpha://company/karyopharm-therapeutics-inc/relationships` (contract): https://registry.alpha.ac/api/public/companies/karyopharm-therapeutics-inc?format=record§ion=relationships - `alpha://company/karyopharm-therapeutics-inc/assessments` (contract): https://registry.alpha.ac/api/public/companies/karyopharm-therapeutics-inc?format=record§ion=assessments - `alpha://company/karyopharm-therapeutics-inc/evidence` (contract): https://registry.alpha.ac/api/public/companies/karyopharm-therapeutics-inc?format=record§ion=evidence ## Role modules - NOT_ASSERTED ## Attention - NO_RECORDS_FOUND ## Committee data - Claim alpha:claim:company:d9e3a59e-f440-41c2-966e-06e1ac24c545:committee_appointment:19: `{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"chair","person":{"alpha_id":"alpha:person:garen-g-bohlin","name":"Garen G. Bohlin"},"source_id":"board_seats"}` - Claim alpha:claim:company:d9e3a59e-f440-41c2-966e-06e1ac24c545:committee_appointment:21: `{"kind":"committee_appointment","original_name":"Compensation","category":"compensation","role":"member","person":{"alpha_id":"alpha:person:barry-e-greene","name":"Barry E. Greene"},"source_id":"board_seats"}` - Claim alpha:claim:company:d9e3a59e-f440-41c2-966e-06e1ac24c545:committee_appointment:22: `{"kind":"committee_appointment","original_name":"Compensation","category":"compensation","role":"member","person":{"alpha_id":"alpha:person:christy-j-oliger","name":"Christy J. Oliger"},"source_id":"board_seats"}` - Claim alpha:claim:company:d9e3a59e-f440-41c2-966e-06e1ac24c545:committee_appointment:24: `{"kind":"committee_appointment","original_name":"Nominating and Governance","category":"nominating_governance","role":"chair","person":{"alpha_id":"alpha:person:barry-e-greene","name":"Barry E. Greene"},"source_id":"board_seats"}` - Claim alpha:claim:company:d9e3a59e-f440-41c2-966e-06e1ac24c545:committee_appointment:25: `{"kind":"committee_appointment","original_name":"Nominating and Governance","category":"nominating_governance","role":"member","person":{"alpha_id":"alpha:person:garen-g-bohlin","name":"Garen G. Bohlin"},"source_id":"board_seats"}` ## Leadership - Barry E. Greene: Director, Compensation; Nominating and Governance · Chair. Claim: alpha:claim:company:d9e3a59e-f440-41c2-966e-06e1ac24c545:leadership_role:5. Valid from: 2013-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:9aaa3bfde545b513f87fac96fac418194d49e78f3e4989e70e8cb3215fb03848. - Christy J. Oliger: Director, Compensation. Claim: alpha:claim:company:d9e3a59e-f440-41c2-966e-06e1ac24c545:leadership_role:6. Valid from: 2020-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:9aaa3bfde545b513f87fac96fac418194d49e78f3e4989e70e8cb3215fb03848. - Cynthia L. Anderson, CPA: Director. Claim: alpha:claim:company:d9e3a59e-f440-41c2-966e-06e1ac24c545:leadership_role:7. Valid from: 2020-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:9aaa3bfde545b513f87fac96fac418194d49e78f3e4989e70e8cb3215fb03848. - Deepika R. Pakianathan, Ph.D.: Director. Claim: alpha:claim:company:d9e3a59e-f440-41c2-966e-06e1ac24c545:leadership_role:8. Valid from: 2013-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:9aaa3bfde545b513f87fac96fac418194d49e78f3e4989e70e8cb3215fb03848. - Garen G. Bohlin: Director, Audit · Chair; Nominating and Governance. Claim: alpha:claim:company:d9e3a59e-f440-41c2-966e-06e1ac24c545:leadership_role:9. Valid from: 2013-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:9aaa3bfde545b513f87fac96fac418194d49e78f3e4989e70e8cb3215fb03848. - Richard Paulson, M.B.A.: Director. Claim: alpha:claim:company:d9e3a59e-f440-41c2-966e-06e1ac24c545:leadership_role:10. Valid from: 2020-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:9aaa3bfde545b513f87fac96fac418194d49e78f3e4989e70e8cb3215fb03848. - Zhen Su, M.D., M.B.A.: Director. Claim: alpha:claim:company:d9e3a59e-f440-41c2-966e-06e1ac24c545:leadership_role:11. Valid from: 2023-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:9aaa3bfde545b513f87fac96fac418194d49e78f3e4989e70e8cb3215fb03848. - Lori Macomber, C.P.A.: Executive Vice President, Chief Financial Officer and Treasurer. Claim: alpha:claim:company:d9e3a59e-f440-41c2-966e-06e1ac24c545:leadership_role:12. Valid from: 2026-02-13. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:ef57edc74878702f0811eb60506abe98b397e61fcb61228ed2035004473d9998. - Michael V. Greco, J.D.: Executive Vice President, Chief Legal Officer and Secretary. Claim: alpha:claim:company:d9e3a59e-f440-41c2-966e-06e1ac24c545:leadership_role:13. Valid from: 2026-02-13. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:95bbbb22949333e43a16e220c74b7417526b35e1b53aad286439a1db79f79c02. - Reshma Rangwala, M.D., Ph.D.: Executive Vice President, Chief Medical Officer. Claim: alpha:claim:company:d9e3a59e-f440-41c2-966e-06e1ac24c545:leadership_role:14. Valid from: 2026-02-13. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:ebf994635e7040faf25c2ef37d8e18e57373479e98542000963e6ed2b050891a. - Richard Paulson, M.B.A.: President and Chief Executive Officer. Claim: alpha:claim:company:d9e3a59e-f440-41c2-966e-06e1ac24c545:leadership_role:15. Valid from: 2026-02-13. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:ec6923005a6d4380fe5376986884ab511b084d3bb22dd25f042ba65fc779d008. - Sohanya Cheng, M.B.A.: Executive Vice President, Chief Commercial Officer. Claim: alpha:claim:company:d9e3a59e-f440-41c2-966e-06e1ac24c545:leadership_role:16. Valid from: 2026-02-13. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:0841f28528460d822d6f959f89aab8cc5a5d337dacae3e05f24f140b17638969. - Stuart Poulton: Executive Vice President, Chief Development Officer. Claim: alpha:claim:company:d9e3a59e-f440-41c2-966e-06e1ac24c545:leadership_role:17. Valid from: 2026-02-13. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:6c6525bd39c9f21f19eb60a5b1f4790da4f8b8945f73bd80caba6c66645d655e. ## Roles - PUBLISHED ## Governance - NOT_ASSERTED ## Board committees - Audit: Chair Garen G. Bohlin; Members Garen G. Bohlin (Chair). Claim: alpha:claim:company:d9e3a59e-f440-41c2-966e-06e1ac24c545:committee_record:18. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:a75dd4830ad63d0088b8bda65efcd3c9d7aaf5d494c08f0ec845bc893acbd986. - Compensation: Chair not stated; Members Barry E. Greene; Christy J. Oliger. Claim: alpha:claim:company:d9e3a59e-f440-41c2-966e-06e1ac24c545:committee_record:20. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:a75dd4830ad63d0088b8bda65efcd3c9d7aaf5d494c08f0ec845bc893acbd986. - Nominating and Governance: Chair Barry E. Greene; Members Barry E. Greene (Chair); Garen G. Bohlin. Claim: alpha:claim:company:d9e3a59e-f440-41c2-966e-06e1ac24c545:committee_record:23. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:a75dd4830ad63d0088b8bda65efcd3c9d7aaf5d494c08f0ec845bc893acbd986. ## Financials - NOT_ASSERTED ## Workforce - NOT_ASSERTED ## Market and index context - PUBLISHED ## Legal Name - Karyopharm Therapeutics Inc.. Claim: alpha:claim:company:d9e3a59e-f440-41c2-966e-06e1ac24c545:legal_name:1. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:6b1ea196221851ab87a4c9620fe4b0ab3d82f8050b13c0c5992d8578c4e1eb89. ## Entity Status - Public listing published. Claim: alpha:claim:company:d9e3a59e-f440-41c2-966e-06e1ac24c545:entity_status:3. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:6b1ea196221851ab87a4c9620fe4b0ab3d82f8050b13c0c5992d8578c4e1eb89. ## Published Fact - US. Claim: alpha:claim:company:d9e3a59e-f440-41c2-966e-06e1ac24c545:published_fact:4. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:6b1ea196221851ab87a4c9620fe4b0ab3d82f8050b13c0c5992d8578c4e1eb89. ## Committee Appointment - Garen G. Bohlin: chair, Audit. Claim: alpha:claim:company:d9e3a59e-f440-41c2-966e-06e1ac24c545:committee_appointment:19. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:a75dd4830ad63d0088b8bda65efcd3c9d7aaf5d494c08f0ec845bc893acbd986. - Barry E. Greene: member, Compensation. Claim: alpha:claim:company:d9e3a59e-f440-41c2-966e-06e1ac24c545:committee_appointment:21. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:a75dd4830ad63d0088b8bda65efcd3c9d7aaf5d494c08f0ec845bc893acbd986. - Christy J. Oliger: member, Compensation. Claim: alpha:claim:company:d9e3a59e-f440-41c2-966e-06e1ac24c545:committee_appointment:22. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:a75dd4830ad63d0088b8bda65efcd3c9d7aaf5d494c08f0ec845bc893acbd986. - Barry E. Greene: chair, Nominating and Governance. Claim: alpha:claim:company:d9e3a59e-f440-41c2-966e-06e1ac24c545:committee_appointment:24. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:a75dd4830ad63d0088b8bda65efcd3c9d7aaf5d494c08f0ec845bc893acbd986. - Garen G. Bohlin: member, Nominating and Governance. Claim: alpha:claim:company:d9e3a59e-f440-41c2-966e-06e1ac24c545:committee_appointment:25. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:a75dd4830ad63d0088b8bda65efcd3c9d7aaf5d494c08f0ec845bc893acbd986. ## Security Listing - KPTI (NASDAQ). Claim: alpha:claim:company:d9e3a59e-f440-41c2-966e-06e1ac24c545:security_listing:26. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:6b1ea196221851ab87a4c9620fe4b0ab3d82f8050b13c0c5992d8578c4e1eb89. ## Coverage states | Field | Value | | --- | --- | | Identity | PUBLISHED | | Business | PUBLISHED | | Leadership | PUBLISHED | | Board and committees | PUBLISHED | | Governance | NOT_ASSERTED | | Financials | NOT_ASSERTED | | Workforce | NOT_ASSERTED | | Ownership | NOT_ASSERTED | | Ratings | NOT_PUBLISHED | | Market and index context | PUBLISHED | ## Public sources - alpha:projection-evidence:6b1ea196221851ab87a4c9620fe4b0ab3d82f8050b13c0c5992d8578c4e1eb89: [Alpha canonical company public projection](https://www.alpha.ac/api/public/companies/karyopharm-therapeutics-inc). - alpha:projection-evidence:document:9aaa3bfde545b513f87fac96fac418194d49e78f3e4989e70e8cb3215fb03848: [Karyopharm Therapeutics Inc. DEF 14A 2026-04-13](https://www.sec.gov/Archives/edgar/data/1503802/000150380226000023/kpti-20260413.htm). - alpha:projection-evidence:document:ef57edc74878702f0811eb60506abe98b397e61fcb61228ed2035004473d9998: [KPTI 10-K executive officers](https://www.sec.gov/Archives/edgar/data/1503802/000119312526049397/kpti-20251231.htm). - alpha:projection-evidence:document:95bbbb22949333e43a16e220c74b7417526b35e1b53aad286439a1db79f79c02: [KPTI 10-K executive officers](https://www.sec.gov/Archives/edgar/data/1503802/000119312526049397/kpti-20251231.htm). - alpha:projection-evidence:document:ebf994635e7040faf25c2ef37d8e18e57373479e98542000963e6ed2b050891a: [KPTI 10-K executive officers](https://www.sec.gov/Archives/edgar/data/1503802/000119312526049397/kpti-20251231.htm). - alpha:projection-evidence:document:ec6923005a6d4380fe5376986884ab511b084d3bb22dd25f042ba65fc779d008: [KPTI 10-K executive officers](https://www.sec.gov/Archives/edgar/data/1503802/000119312526049397/kpti-20251231.htm). - alpha:projection-evidence:document:0841f28528460d822d6f959f89aab8cc5a5d337dacae3e05f24f140b17638969: [KPTI 10-K executive officers](https://www.sec.gov/Archives/edgar/data/1503802/000119312526049397/kpti-20251231.htm). - alpha:projection-evidence:document:6c6525bd39c9f21f19eb60a5b1f4790da4f8b8945f73bd80caba6c66645d655e: [KPTI 10-K executive officers](https://www.sec.gov/Archives/edgar/data/1503802/000119312526049397/kpti-20251231.htm). - alpha:projection-evidence:a75dd4830ad63d0088b8bda65efcd3c9d7aaf5d494c08f0ec845bc893acbd986: [Audit](https://www.sec.gov/Archives/edgar/data/1503802/000150380226000023/kpti-20260413.htm). ## Rights | Field | Value | | --- | --- | | public_retrieval | allowed | | agent_retrieval | allowed | | redistribution | not_granted | | model_training | not_granted | | commercial_use | not_specified | | relationship_pathfinding | not_granted | | direct_contact | not_granted | ## Limitations - Absence of a leadership role, committee, or disclosure is not evidence that it does not exist. - Only explicitly published canonical company identity and current confirmed public roles are included. - Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist. - Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights. - This Company Profile is an identity and evidence record, not an Alpha rating. ## Alternate representations - [Canonical profile](https://registry.alpha.ac/companies/karyopharm-therapeutics-inc) - [Public Markdown](https://registry.alpha.ac/companies/karyopharm-therapeutics-inc.md) - [Public JSON](https://registry.alpha.ac/api/public/companies/karyopharm-therapeutics-inc?format=record) - [JSON-LD](https://registry.alpha.ac/api/public/companies/karyopharm-therapeutics-inc?format=jsonld) - MCP resource: `alpha://companies/karyopharm-therapeutics-inc` at https://mcp.alpha.ac/mcp ## Connected governance records Only explicitly published, rights-cleared records. Missing records do not establish absence, safety, or complete coverage. ## Critical-risk oversight Snapshot as of 2026-10-16T17:33:15.478654+00:00; recorded 2026-10-16T17:33:15.478654+00:00. Every published assignment for this snapshot is listed. Only explicitly reviewed, rights-cleared assignments in effect on the as-of date, in the company's own wording. An assignment shows where oversight is placed, not whether it is effective. Missing records do not establish absence.